# A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: Children's Oncology Group · Condition: Rhabdomyosarcoma

- Company: Children's Oncology Group
- Sector: Rhabdomyosarcoma
- Primary source: https://clinicaltrials.gov/study/NCT07466316

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.